Scorpius Holdings, Inc. (SCPX)
Scorpius Holdings, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in San Antonio, TX, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $14,865. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -580.7%. Its beta of -5.33 implies it has historically moved less than the broad market.
Scorpius Holdings, Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company engages in clinical and commercial drug substance manufacturing; and release and stability testing activities. It is also involved in the provision of various process development services, including upstream and downstream development and optimization, and analytical method development solutions, as well as cell line development, testing, and characterization services. The company serves the biotechnology and biopharmaceutical industries. The company was formerly known as NightHawk Biosciences, Inc. and changed its name to Scorpius Holdings, Inc. in February 2024. Scorpius Holdings, Inc. was incorporated in 2008 and is based in San Antonio, Texas.
Scorpius Holdings, Inc. is most often compared with the following Healthcare names: